Stockreport

Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics [TechCrunch Blog]

ATAI Life Sciences N.V. - Common Shares  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression. It’s has raised $290 mill [Read more]